Delivery Order SPE2DB22D3301-SPE2DB25FX4KD
Award Date
10/25/24
Potential Completion Date
11/18/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,641.02 Firm Fixed Price Delivery Order is for the supply of HEMLIBRA 150 MG/ML VIALML, a specialty medication. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, SPE2DX15D3020|SPE2DX24FPYNY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $33,409.40 firm fixed-price delivery order is for the supply of HEMLIBRA 150 MG/ML vials, a specialty pharmaceutical product, with an ultimate completion date of October 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a medication, with a firm fixed price of $24,673.08 and a period of performance ending on July 18, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp is the prime contractor and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the purchase of HEMLIBRA 150 MG/ML vials. The delivery order has a ceiling value of $16,704.72 and is a firm-fixed price contract, with an ultimate completion date of September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of essential medical commodities, including specialty medications, brand-name and...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $23,330.40 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,565,282 units of the specialty pharmaceutical product Hemlibra (105 mg/0.7 ml vial). The contract has an ultimate completion date of August 19, 2024 and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of HYPERHEP B VIAL 5ML medical supplies. The $1,972.74 firm fixed-price delivery order has a completion date of November 21, 2023 and was awarded on October 30, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,745.16, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of $999,999,999 and runs through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,925.56 firm fixed-price delivery order, awarded on January 12, 2023, is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that runs through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies,...
The federal contract award is for the delivery of HYPERHEP B VIAL 5ML to the Defense Logistics Agency (DLA), a defense agency. The $1,345.86 firm-fixed-price delivery order was awarded on May 22, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of June 13, 2025. This delivery order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This federal contract award, valued at $374,451.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...